Daniel J. Cantillon

Cleveland Clinic Academic Setting

Author of 17 ePosters

 eCatalog Module
Cardiovascular Implantable Electronic Devices -> Leads & Electrodes: -> Extraction/Removal D-AB05 - Leadless Pacing: What's Up? (ID 17) Abstract Plus
No eCatalog Preview Available

D-AB05-04 - Evaluation Of Strategies And Techniques Leading To Safe And Successful NanostimTmLeadless Pacemaker Extraction (ID 762)

Authors
Disclosure
  P. Neuzil: Honoraria/Speaking/Consulting Fee - Abbott.
Heart Failure -> Cardiac Resynchronization Therapy: -> Indications D-AB13 - Beyond ICM and NICM: CRT in Emerging HF Populations (ID 54) Abstract

D-AB13-04 - Impact Of Cardiac Resynchronization Therapy On Survival In Patients With Transthyretin Cardiac Amyloidosis (ID 1432)

Authors
Disclosure
 E. Donnellan: Nothing relevant to disclose.
Cardiovascular Implantable Electronic Devices -> Tachycardia Devices: -> Indications D-AB21 - Real World Outcomes of Patients with an ICD (ID 7) Abstract

D-AB21-06 - Impact Of Primary Prevention Implantable Cardioverter-defibrillators On Survival In Patients With Transthyretin Cardiac Amyloidosis (ID 1451)

Authors
Disclosure
 E. Donnellan: Nothing relevant to disclose.
Clinical Electrophysiology -> Atrial Fibrillation & Atrial Flutter: -> Pharmacology (Antiarrhythmic drugs and anticoagulants) D-AB27 - Arrhythmias, infiltration and hypertrophy (ID 27) Abstract

D-AB27-02 - Rates Of Bleeding Requiring Anticoagulation Cessation In Patients With Transthyretin Cardiac Amyloidosis And Atrial Fibrillation (ID 1465)

Authors
Disclosure
 E. Donnellan: Nothing relevant to disclose.
Clinical Electrophysiology -> Atrial Fibrillation & Atrial Flutter: -> Pharmacology (Antiarrhythmic drugs and anticoagulants) D-BT01 - Cardiac Electrophysiology Society (CES): Lunch and Young Investigator Award Poster Session (ID 41) Special Session

D-BT01-30 - Rates Of Bleeding Requiring Anticoagulation Cessation In Patients With Transthyretin Cardiac Amyloidosis And Atrial Fibrillation (ID 864)

Authors
Disclosure
 E. Donnellan: Nothing relevant to disclose.
Heart Failure -> Cardiac Resynchronization Therapy: -> Indications D-BT01 - Cardiac Electrophysiology Society (CES): Lunch and Young Investigator Award Poster Session (ID 41) Special Session

D-BT01-32 - Impact Of Cardiac Resynchronization Therapy On Survival In Patients With Transthyretin Cardiac Amyloidosis (ID 866)

Authors
Disclosure
 E. Donnellan: Nothing relevant to disclose.
Provocative Cases -> Teaching Case Reports D-PO01 - Featured Poster Session (ID 11) Poster

D-PO01-108 - Discrete Activation From The Left Atrium Inside The Coronary Sinus And The Marshall Vein As A Part Of Tachycardia Circuit: A Case Of Left Sided Atrial Tachycardia (ID 96)

Authors
Disclosure
 K. Higuchi: Nothing relevant to disclose.
Allied Professionals (Non-physician submissions only) -> Clinical Research D-PO03 - Poster Session III (ID 48) Poster
No eCatalog Preview Available

D-PO03-040 - Patient And Physician Experience In Using Virtual Visits In Cardiac Electrophysiology (ID 286)

Authors
Disclosure

 M. Eppich: Nothing relevant to disclose.

Video File Upload
Catheter Ablation -> Atrial Fibrillation & Atrial Flutter: -> Clinical Trials / Outcomes D-PO03 - Poster Session III (ID 48) Poster

D-PO03-195 - Impact Of Risk Factor Modification On Arrhythmia Recurrence Rates Following Atrial Fibrillation Ablation In Nonalcoholic Fatty Liver Disease (ID 1151)

Authors
Disclosure
 E. Donnellan: Nothing relevant to disclose.
Clinical Electrophysiology -> SCA Risk Assessment: -> Clinical Risk Assessment Techniques D-PO04 - Poster Session IV (ID 15) Poster

D-PO04-213 - Sudden Cardiac Arrest Prevention Utilizing A Vendor-agnostic, Rank Order Detection Algorithm Among Non-ICU Hospitalized Patients: The Enhanced Central Monitoring Unit (eCMU) (ID 498)

Authors
Cardiovascular Implantable Electronic Devices -> Monitoring & Outcomes: -> Quality Measures & Complications D-PO05 - Poster Session V (ID 39) Poster

D-PO05-099 - Incidence Of Cardiac Implantable Electronic Device Complications In Patients With Left Ventricular Assist Devices (ID 1266)

Authors
Disclosure
 J.L. Gilge: Nothing relevant to disclose.
Cardiovascular Implantable Electronic Devices -> Monitoring & Outcomes: -> Quality Measures & Complications D-PO05 - Poster Session V (ID 39) Poster

D-PO05-103 - Proarrhythmic Effects From Competitive Atrial Pacing And Potential Programming Solutions (ID 551)

Authors
Disclosure
 S.Y. Wass: Nothing relevant to disclose.
Catheter Ablation -> Atrial Fibrillation & Atrial Flutter: -> Quality Measures & Complications D-PO05 - Poster Session V (ID 39) Poster

D-PO05-127 - Patient Reported Outcomes And Quality Of Life In Patients With Or Without Arrhythmia Recurrence After Atrial Fibrillation Ablation (ID 559)

Authors
Disclosure
 M. Diab: Nothing relevant to disclose.
Catheter Ablation -> Atrial Fibrillation & Atrial Flutter: -> Quality Measures & Complications D-PO05 - Poster Session V (ID 39) Poster

D-PO05-144 - Recurrence Of Atrial Fibrillation After Redo Catheter Ablation: Implications Of Non-pulmonary Vein Triggers (ID 1278)

Authors
Disclosure
 E. Hutt: Nothing relevant to disclose.
Catheter Ablation -> SVT/AVNRT/WPW/AT: -> Ablation Techniques D-PO05 - Poster Session V (ID 39) Poster

D-PO05-152 - Systematic Review And Meta-analysis Of Zero Or Near-zero Fluoroscopy Use During Arrhythmia Ablation (ID 570)

Authors
Disclosure
 S. Alkharabsheh: Nothing relevant to disclose.
Catheter Ablation -> Ventricular Arrhythmias -> Clinical Trials / Outcomes D-PO05 - Poster Session V (ID 39) Poster

D-PO05-203 - Early Recurrence Of Ventricular Tachycardia Following Ablation And Mortality (ID 593)

Authors
Disclosure
 J.A. Ballout: Nothing relevant to disclose.
Catheter Ablation -> Ventricular Arrhythmias -> Clinical Trials / Outcomes D-PO05 - Poster Session V (ID 39) Poster

D-PO05-204 - Ventricular Tachycardia Ablation In Patients With Continuous Flow Left Ventricular Assist Device (ID 594)

Authors
Disclosure
 J.A. Ballout: Nothing relevant to disclose.